Update date
31 Dec 2024
Shareable Research Card
This metric view shows MRM - Medirom Healthcare Technologies Inc. contract with customer, liability, current history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest reported contract with customer, liability, current: ¥53,485,000. Open the source-backed page to compare this metric with the newest filing-backed context.
Update date
31 Dec 2024
Page type
Metric history
Latest period
Q4 2024
SEC-backed company facts were refreshed from filings filed on 29 Apr 2025.
Benchmark Context
Medirom Healthcare Technologies Inc. sits in the lower half of the current contract with customer, liability, current sample.
Compared with
Compared with 7 companies reporting contract with customer, liability, current in JPY. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 1x the current sample midpoint. Contract with Customer, Liability, Current is down about 51% versus the comparable prior period.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Financial Metric Page
Latest period: Q4 2024. Period end: 31 Dec 2024. Units: JPY. Frequency: quarterly.
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Direct filing link is shown only when a matched SEC filing document is available for this metric context.
Compare latest available Contract with Customer, Liability, Current levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
Medirom Healthcare Technologies Inc. appears at rank #5 in the latest comparison sample.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | LEAD REAL ESTATE CO., LTD (lre) | ¥337,483,000 | Instant - 30 Jun 2025 | Open LEAD REAL ESTATE CO., LTD Contract with Customer, Liability, Current |
| 2 | LOGPROSTYLE INC. (lgps) | ¥252,260,000 | Instant - 31 Mar 2025 | Open LOGPROSTYLE INC. Contract with Customer, Liability, Current |
| 3 | LEIFRAS Co., Ltd. (lfs) | ¥154,074,620 | Instant - 31 Dec 2025 | Open LEIFRAS Co., Ltd. Contract with Customer, Liability, Current |
| 4 | PicoCELA Inc. (pcla) | ¥55,084,000 | Instant - 30 Sep 2025 | Open PicoCELA Inc. Contract with Customer, Liability, Current |
| 5 | Medirom Healthcare Technologies Inc. (mrm) | ¥53,485,000 | Instant - 31 Dec 2024 | Open Medirom Healthcare Technologies Inc. Contract with Customer, Liability, Current |
| 6 | PIXIE DUST TECHNOLOGIES, INC. | ¥6,523,000 | Instant - 30 Apr 2024 | Open PIXIE DUST TECHNOLOGIES, INC. Contract with Customer, Liability, Current |
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2024 | ¥53,485,000 | -¥55,822,000 | -51% | 31 Dec 2024 | 20-F | 29 Apr 2025 | 2024 | FY |
| Q4 2023 | ¥109,307,000 | +¥20,299,000 | +23% | 31 Dec 2023 | 20-F | 29 Apr 2025 | 2024 | FY |
| Q4 2022 | ¥89,008,000 | -¥15,174,000 | -15% | 31 Dec 2022 | 20-F | 18 Jun 2024 | 2023 | FY |
| Q4 2021 | ¥104,182,000 | -¥67,881,000 | -39% | 31 Dec 2021 | 20-F | 30 May 2023 | 2022 | FY |
| Q4 2020 | ¥172,063,000 | -¥29,496,000 | -15% | 31 Dec 2020 | 20-F | 14 Nov 2022 | 2021 | FY |
| Q4 2019 | ¥201,559,000 | 31 Dec 2019 | 20-F | 17 May 2021 | 2020 | FY |